Position in QNCX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$181
-$23,235 QoQ
Shares Held
10
-71.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 25 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in QNCX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. QNCX ranks #382 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in QNCX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $181 | 10 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $23,416 | 6,990 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11,393 | 6,990 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,533 | 6,990 | Shares | Defined | 2025-08-14 | |
| 2024-03-31 | $284 | 268 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,327 | 1,264 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,357 | 1,212 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $231 | 154 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $229 | 147 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $92 | 145 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,727 | 1,299 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,047 | 1,373 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $114,625 | 18,518 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $458,988 | 36,370 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $906,883 | 9,894 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $657,094 | 12,398 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $425,694 | 11,815 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $877,791 | 31,598 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $775,450 | 15,509 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $857,983 | 18,531 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $723,601 | 15,865 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||